Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study

Sarah Lessire; Jonathan Douxfils; Justine Baudar; Nicolas Bailly; Anne Sophie Dincq; Maximilien Gourdin; Jean Michel Dogné; Bernard Chatelain; François Mullier

doi:10.1016/j.thromres.2015.07.018

Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study

Sarah Lessire, Jonathan Douxfils, Justine Baudar, Nicolas Bailly, Anne Sophie Dincq, Maximilien Gourdin, Jean Michel Dogné, Bernard Chatelain, François Mullier

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	693-696
Number of pages	4
Journal	Thrombosis Research
Volume	136
Issue number	3
DOIs	https://doi.org/10.1016/j.thromres.2015.07.018
Publication status	Published - 1 Sept 2015

Keywords

Abbreviations HTI Hemoclot Thombin Inhibitors®
CV% Coefficient of variation expressed in percentage
ECA Ecarin chromogenic assay
LOD Limit of detection
LOQ Limit of quantification
NIH/ml National Institutes of Health (NIH) units per ml
NPP Normal pool plasma
OTC Optimal thrombin concentration
PPP Platelet-poor-plasma
SD Standard deviation
T<inf>MAX</inf> Limit of measurement of thrombin time
TT Thrombin time
UFH Unfractionated heparin

Access to Document

10.1016/j.thromres.2015.07.018

Cite this

@article{466e99c944b945ff85a01975549ee048,

title = "Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study",

keywords = "Abbreviations HTI Hemoclot Thombin Inhibitors{\textregistered}, CV% Coefficient of variation expressed in percentage, ECA Ecarin chromogenic assay, LOD Limit of detection, LOQ Limit of quantification, NIH/ml National Institutes of Health (NIH) units per ml, NPP Normal pool plasma, OTC Optimal thrombin concentration, PPP Platelet-poor-plasma, SD Standard deviation, T<inf>MAX</inf> Limit of measurement of thrombin time, TT Thrombin time, UFH Unfractionated heparin",

author = "Sarah Lessire and Jonathan Douxfils and Justine Baudar and Nicolas Bailly and Dincq, {Anne Sophie} and Maximilien Gourdin and Dogn{\'e}, {Jean Michel} and Bernard Chatelain and Fran{\c c}ois Mullier",

year = "2015",

month = sep,

day = "1",

doi = "10.1016/j.thromres.2015.07.018",

language = "English",

volume = "136",

pages = "693--696",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study

AU - Lessire, Sarah

AU - Douxfils, Jonathan

AU - Baudar, Justine

AU - Bailly, Nicolas

AU - Dincq, Anne Sophie

AU - Gourdin, Maximilien

AU - Dogné, Jean Michel

AU - Chatelain, Bernard

AU - Mullier, François

PY - 2015/9/1

Y1 - 2015/9/1

KW - Abbreviations HTI Hemoclot Thombin Inhibitors®

KW - CV% Coefficient of variation expressed in percentage

KW - ECA Ecarin chromogenic assay

KW - LOD Limit of detection

KW - LOQ Limit of quantification

KW - NIH/ml National Institutes of Health (NIH) units per ml

KW - NPP Normal pool plasma

KW - OTC Optimal thrombin concentration

KW - PPP Platelet-poor-plasma

KW - SD Standard deviation

KW - T<inf>MAX</inf> Limit of measurement of thrombin time

KW - TT Thrombin time

KW - UFH Unfractionated heparin

UR - http://www.scopus.com/inward/record.url?scp=84940440202&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2015.07.018

DO - 10.1016/j.thromres.2015.07.018

M3 - Article

C2 - 26251077

SN - 0049-3848

VL - 136

SP - 693

EP - 696

JO - Thrombosis Research

JF - Thrombosis Research

IS - 3

ER -

Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study

Keywords

Access to Document

Other files and links

Optimization of the perioperative management of direct oral anticoagulants

Cite this

Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study

Keywords

Access to Document

Other files and links

Student theses

Optimization of the perioperative management of direct oral anticoagulants

Cite this